Literature DB >> 9624151

Inhibition of the self-assembly of collagen I into fibrils with synthetic peptides. Demonstration that assembly is driven by specific binding sites on the monomers.

D J Prockop1, A Fertala.   

Abstract

A series of experiments were carried out to test the hypothesis that the self-assembly of collagen I monomers into fibrils depends on the interactions of specific binding sites in different regions of the monomer. Six synthetic peptides were prepared with sequences found either in the collagen triple helix or in the N- or C-telopeptides of collagen I. The four peptides with sequences found in the telopeptides were found to inhibit self-assembly of collagen I in a purified in vitro system. At concentrations of 2.5 mM, peptides with sequences in the C-telopeptides of the alpha1(I) and alpha2(I) chain inhibited assembly at about 95%. The addition of the peptide with the alpha2-telopeptide sequence was effective in inhibiting assembly if added during the lag phase and early propagation phase but not later in the assembly process. Experiments with biotinylated peptides indicated that both the N- and C-telopeptides bound to a region between amino acid 776 and 822 of the alpha(I) chain. A fragment of nine amino acids with sequences in the alpha2-telopeptide was effective in inhibiting fibril assembly. Mutating two aspartates in the 9-mer peptide to serine had no effect on inhibition of fibril assembly, but mutating two tyrosine residues and one phenylalanine residue abolished the inhibitory action. Molecular modeling of the binding sites demonstrated favorable hydrophobic and electrostatic interactions between the alpha2telopeptide and residues 781-794 of the alpha(I) chain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9624151     DOI: 10.1074/jbc.273.25.15598

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Corneal collagen fibril structure in three dimensions: Structural insights into fibril assembly, mechanical properties, and tissue organization.

Authors:  D F Holmes; C J Gilpin; C Baldock; U Ziese; A J Koster; K E Kadler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

2.  Mapping Hsp47 binding site(s) using CNBr peptides derived from type I and type II collagen.

Authors:  Christy A Thomson; Ruggero Tenni; Vettai S Ananthanarayanan
Journal:  Protein Sci       Date:  2003-08       Impact factor: 6.725

3.  Prospects and limitations of the rational engineering of fibrillar collagens.

Authors:  Ireneusz Majsterek; Erin McAdams; Eijiro Adachi; Shirish T Dhume; Andrzej Fertala
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

4.  Vascular smooth muscle cells orchestrate the assembly of type I collagen via alpha2beta1 integrin, RhoA, and fibronectin polymerization.

Authors:  Shaohua Li; Caroline Van Den Diepstraten; Sudhir J D'Souza; Bosco M C Chan; J Geoffrey Pickering
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

5.  Collagen fibril formation. A new target to limit fibrosis.

Authors:  Hye Jin Chung; Andrzej Steplewski; Kee Yang Chung; Jouni Uitto; Andrzej Fertala
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

6.  Thermal memory in self-assembled collagen fibril networks.

Authors:  Martijn de Wild; Wim Pomp; Gijsje H Koenderink
Journal:  Biophys J       Date:  2013-07-02       Impact factor: 4.033

7.  The Tyrosine Sulfate Domain of Fibromodulin Binds Collagen and Enhances Fibril Formation.

Authors:  Viveka Tillgren; Matthias Mörgelin; Patrik Önnerfjord; Sebastian Kalamajski; Anders Aspberg
Journal:  J Biol Chem       Date:  2016-09-15       Impact factor: 5.157

8.  Mapping of SPARC/BM-40/osteonectin-binding sites on fibrillar collagens.

Authors:  Camilla Giudici; Nicolas Raynal; Hanna Wiedemann; Wayne A Cabral; Joan C Marini; Rupert Timpl; Hans Peter Bächinger; Richard W Farndale; Takako Sasaki; Ruggero Tenni
Journal:  J Biol Chem       Date:  2008-05-16       Impact factor: 5.157

Review 9.  Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.

Authors:  Joan C Marini; Antonella Forlino; Wayne A Cabral; Aileen M Barnes; James D San Antonio; Sarah Milgrom; James C Hyland; Jarmo Körkkö; Darwin J Prockop; Anne De Paepe; Paul Coucke; Sofie Symoens; Francis H Glorieux; Peter J Roughley; Alan M Lund; Kaija Kuurila-Svahn; Heini Hartikka; Daniel H Cohn; Deborah Krakow; Monica Mottes; Ulrike Schwarze; Diana Chen; Kathleen Yang; Christine Kuslich; James Troendle; Raymond Dalgleish; Peter H Byers
Journal:  Hum Mutat       Date:  2007-03       Impact factor: 4.878

10.  Engineering and characterization of the chimeric antibody that targets the C-terminal telopeptide of the α2 chain of human collagen I: a next step in the quest to reduce localized fibrosis.

Authors:  Jolanta Fertala; Andrzej Steplewski; James Kostas; Pedro Beredjiklian; Gerard Williams; William Arnold; Joseph Abboud; Anshul Bhardwaj; Cheryl Hou; Andrzej Fertala
Journal:  Connect Tissue Res       Date:  2013-04-15       Impact factor: 3.417

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.